Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Gilead Sciences, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $81.3 Billion
- Q2 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 1,758,645 shares of GILD stock, worth $155 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,758,645
Previous 1,571,510
11.91%
Holding current value
$155 Million
Previous $115 Million
4.82%
% of portfolio
0.15%
Previous 0.16%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
1,893Shares Held
1.02BCall Options Held
12MPut Options Held
9.04M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.72 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.32 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.23 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...